Jpmorgan Chase & Co »

Ampio Pharmaceuticals shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Ampio Pharmaceuticals (AMPE) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Ampio Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ampio Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ampio Pharmaceuticals by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $206 101 2.05
2023-09-30 $368 101 3.64

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Nvidia Corporation Common (NVDA)
Meta Platforms Common (META)
Unitedhealth Group Common (UNH)
Vanguard Total Intl Bond Etf Fund (BNDX)
Alphabet Common (GOOG)
Eli Lilly & Co Common (LLY)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Abbvie Common (ABBV)
Vanguard Total Bond Market Fund (BND)
Tesla Common (TSLA)

View all positions for Jpmorgan Chase & Co

Top funds holding Ampio Pharmaceuticals

Hrt Financial
CVA Family Office
Cypress Capital Management
Advisor Group Holdings
GHP Investment Advisors
Sunbelt Securities
Jpmorgan Chase & Co
JFS Wealth Advisors
JJJ Advisors
Bank of America Corporation
Wells Fargo & Company
Newbridge Financial Services Group
Farther Finance Advisors
Sanctuary Wealth Management
SRS Capital Advisors

View all funds holding Ampio Pharmaceuticals